﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" returnVersion="2013v3.1">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2014-09-15T13:10:59-05:00</ReturnTs>
    <TaxPeriodEndDt>2014-04-30</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmEIN>571036627</PreparerFirmEIN>
      <PreparerFirmName>
        <BusinessNameLine1>TAYLOR MILES &amp; ASSOCIATES PA</BusinessNameLine1>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1>1940 TROLLEY RD STE A</AddressLine1>
        <City>SUMMERVILLE</City>
        <State>SC</State>
        <ZIPCode>29485</ZIPCode>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990</ReturnTypeCd>
    <TaxPeriodBeginDt>2013-05-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>272227360</EIN>
      <BusinessName>
        <BusinessNameLine1>CHASE AFTER A CURE INC</BusinessNameLine1>
      </BusinessName>
      <BusinessNameControlTxt>CHAS</BusinessNameControlTxt>
      <PhoneNum>8432702954</PhoneNum>
      <USAddress>
        <AddressLine1>89B OLD TROLLEY ROAD SUITE 201</AddressLine1>
        <City>SUMMERVILLE</City>
        <State>SC</State>
        <ZIPCode>29485</ZIPCode>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>WHITNEY</PersonNm>
      <PersonTitleTxt>RINGLER</PersonTitleTxt>
      <PhoneNum>8432702954</PhoneNum>
      <SignatureDt>2014-09-11</SignatureDt>
      <DiscussWithPaidPreparerInd>true</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <PreparerPersonGrp>
      <PreparerPersonNm>LORI A MILES CPA</PreparerPersonNm>
      <PTIN>P00303811</PTIN>
      <PhoneNum>8438751774</PhoneNum>
      <PreparationDt>2014-09-15</PreparationDt>
    </PreparerPersonGrp>
    <TaxYr>2013</TaxYr>
    <BuildTS>2015-11-30 17:44:51Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCount="6">
    <IRS990 documentId="RetDoc1" referenceDocumentId="RetDoc6">
      <PrincipalOfficerNm>WHITNEY RINGLER</PrincipalOfficerNm>
      <USAddress>
        <AddressLine1>123 PINE VALLEY DRIVE</AddressLine1>
        <City>SUMMERVILLE</City>
        <State>SC</State>
        <ZIPCode>29483</ZIPCode>
      </USAddress>
      <GrossReceiptsAmt>238945</GrossReceiptsAmt>
      <GroupReturnForAffiliatesInd>false</GroupReturnForAffiliatesInd>
      <Organization501c3Ind>X</Organization501c3Ind>
      <WebsiteAddressTxt>CHASEAFTERACURE.COM</WebsiteAddressTxt>
      <TypeOfOrganizationCorpInd>X</TypeOfOrganizationCorpInd>
      <FormationYr>2010</FormationYr>
      <LegalDomicileStateCd>SC</LegalDomicileStateCd>
      <ActivityOrMissionDesc>CHASE AFTER A CURE IS A NON-PROFIT CORPORATION DEDICATED TO CHILDREN'S CANCER RESEARCH. WE RAISE AWARENESS FOR CHILDREN'S CANCER AND PROVIDE FUNDING FOR RESEARCH LABS WHO SPECIALIZE IN CHILDREN'S CANCER RESEARCH. OUR MAIN FOCUS FOR RESEARCH IS THE MORE AGGRESSIVE AND DEADLY CANCER CALLED NEUROBLASOMA.</ActivityOrMissionDesc>
      <VotingMembersGoverningBodyCnt>4</VotingMembersGoverningBodyCnt>
      <VotingMembersIndependentCnt>4</VotingMembersIndependentCnt>
      <TotalEmployeeCnt>1</TotalEmployeeCnt>
      <TotalVolunteersCnt>40</TotalVolunteersCnt>
      <TotalGrossUBIAmt>0</TotalGrossUBIAmt>
      <PYContributionsGrantsAmt>18052</PYContributionsGrantsAmt>
      <CYContributionsGrantsAmt>72291</CYContributionsGrantsAmt>
      <CYProgramServiceRevenueAmt>0</CYProgramServiceRevenueAmt>
      <CYInvestmentIncomeAmt>0</CYInvestmentIncomeAmt>
      <PYOtherRevenueAmt>163226</PYOtherRevenueAmt>
      <CYOtherRevenueAmt>108250</CYOtherRevenueAmt>
      <PYTotalRevenueAmt>181278</PYTotalRevenueAmt>
      <CYTotalRevenueAmt>180541</CYTotalRevenueAmt>
      <PYGrantsAndSimilarPaidAmt>150000</PYGrantsAndSimilarPaidAmt>
      <CYGrantsAndSimilarPaidAmt>130000</CYGrantsAndSimilarPaidAmt>
      <CYBenefitsPaidToMembersAmt>0</CYBenefitsPaidToMembersAmt>
      <CYSalariesCompEmpBnftPaidAmt>27029</CYSalariesCompEmpBnftPaidAmt>
      <CYTotalProfFndrsngExpnsAmt>0</CYTotalProfFndrsngExpnsAmt>
      <CYTotalFundraisingExpenseAmt>23334</CYTotalFundraisingExpenseAmt>
      <PYOtherExpensesAmt>28479</PYOtherExpensesAmt>
      <CYOtherExpensesAmt>24790</CYOtherExpensesAmt>
      <PYTotalExpensesAmt>178479</PYTotalExpensesAmt>
      <CYTotalExpensesAmt>181819</CYTotalExpensesAmt>
      <PYRevenuesLessExpensesAmt>2799</PYRevenuesLessExpensesAmt>
      <CYRevenuesLessExpensesAmt>-1278</CYRevenuesLessExpensesAmt>
      <TotalAssetsBOYAmt>45126</TotalAssetsBOYAmt>
      <TotalAssetsEOYAmt>44037</TotalAssetsEOYAmt>
      <TotalLiabilitiesBOYAmt>1791</TotalLiabilitiesBOYAmt>
      <TotalLiabilitiesEOYAmt>1980</TotalLiabilitiesEOYAmt>
      <NetAssetsOrFundBalancesBOYAmt>43335</NetAssetsOrFundBalancesBOYAmt>
      <NetAssetsOrFundBalancesEOYAmt>42057</NetAssetsOrFundBalancesEOYAmt>
      <InfoInScheduleOPartIIIInd>X</InfoInScheduleOPartIIIInd>
      <MissionDesc>CHASE AFTER A CURE IS A NON-PROFIT CORPORATION DEDICATED TO CHILDREN'S CANCER RESEARCH. WE RAISE AWARENESS FOR CHILDREN'S CANCER AND PROVIDE FUNDING FOR RESEARCH LABS WHO SPECIALIZE IN CHILDREN'S CANCER RESEARCH. OUR MAIN FOCUS FOR RESEARCH IS THE MORE AGGRESSIVE AND DEADLY CANCER CALLED NEUROBLASOMA.</MissionDesc>
      <SignificantNewProgramSrvcInd>false</SignificantNewProgramSrvcInd>
      <SignificantChangeInd>false</SignificantChangeInd>
      <ExpenseAmt>142517</ExpenseAmt>
      <GrantAmt>130000</GrantAmt>
      <Desc>SEE SCHEDULE O APPLIED AND WERE AWARDED A 10,000 GRANT FROM THE EXCHANGE CLUB OF CHARLESTON. FUNDS FROM THIS GRANT WERE REQUESTED TO HELP FUND THE PURCHASE OF AN IMAGER IN THE LAB TO STUDY THE AMOUNTS OF SPHINGOLIPID PROTEIN IN NEUROBLASTOMA CELL LINES AND TUMORS. THIS DEVICE WILL ALSO MEASURE THE CHANGES IN THE AMOUNTS OF PROTEIN IN NEUROBLASTOMA CELLS AND TUMORS AFTER TREATMENTS WITH THE INHIBITORS DEVELOPED BY THE LAB. SUPPORT FOR CHASE AFTER A CURE HAS RESULTED IN 10 PUBLICATIONS, OVER 200 CITATIONS, 3 INVITED PRESENTATIONS, 15 ORAL AND POSTER PRESENTATIONS, AND NATIONAL AND INTERNATIONAL MEETINGS. THE LOCAL RESEARCH LAB WAS ABLE TO GENERATE PRELIMINARY DATA THAT SUPPORTED PROPOSALS FOR PEER-REVIEWED FUNDING FROM THE NATIONAL CHILDHOOD CANCER FOUNDATIONS, HYUNDAI HOPE ON WHEELS, RALLY FOUNDATION FOR PEDIATRIC CANCER RESEARCH, AND THE ST. BALDRICK'S FOUNDATION. FUNDS HAVE HELPED SUPPORT THE WORK OF THREE SCIENTISTS IN THE LAB. PURCHASE KEY EQUIPMENT FOR THE LAB SUCH AS: EVOS FLOURESCENT MIRCROSCOPE USED TO VISUALIZE DRUG TREATMENTS, BIOTEK SYNERGY H1 MULTI-MODE PLATE READER USED FOR CANCER CELL DEATH ASSAYS, ENZYME ASSAYS, CANCER CELL DRUG DISCOVERY EXPERIMENTS, AND BIORAD CFX96 TOUCH REAL-TIME PCR THERMAL CYCLER USED FOR CANCER CELL GENE EXPRESSION ANALYSIS. SUBSIDIZED THE COST OF LAB EXPERIMENTS AND CONSUMABLES SUCH AS REAGENTS, PIPETTES, AND TISSUE CULTURE PLATES.</Desc>
      <TotalProgramServiceExpensesAmt>142517</TotalProgramServiceExpensesAmt>
      <DescribedInSection501c3Ind referenceDocumentId="RetDoc2">true</DescribedInSection501c3Ind>
      <ScheduleBRequiredInd>false</ScheduleBRequiredInd>
      <PoliticalCampaignActyInd>false</PoliticalCampaignActyInd>
      <LobbyingActivitiesInd>false</LobbyingActivitiesInd>
      <SubjectToProxyTaxInd>false</SubjectToProxyTaxInd>
      <DonorAdvisedFundInd referenceDocumentId="RetDoc3">true</DonorAdvisedFundInd>
      <ConservationEasementsInd referenceDocumentId="RetDoc3">false</ConservationEasementsInd>
      <CollectionsOfArtInd referenceDocumentId="RetDoc3">false</CollectionsOfArtInd>
      <CreditCounselingInd referenceDocumentId="RetDoc3">false</CreditCounselingInd>
      <TempOrPermanentEndowmentsInd referenceDocumentId="RetDoc3">false</TempOrPermanentEndowmentsInd>
      <ReportLandBuildingEquipmentInd referenceDocumentId="RetDoc3">false</ReportLandBuildingEquipmentInd>
      <ReportInvestmentsOtherSecInd referenceDocumentId="RetDoc3">false</ReportInvestmentsOtherSecInd>
      <ReportProgramRelatedInvstInd referenceDocumentId="RetDoc3">false</ReportProgramRelatedInvstInd>
      <ReportOtherAssetsInd referenceDocumentId="RetDoc3">false</ReportOtherAssetsInd>
      <ReportOtherLiabilitiesInd referenceDocumentId="RetDoc3">false</ReportOtherLiabilitiesInd>
      <IncludeFIN48FootnoteInd referenceDocumentId="RetDoc3">false</IncludeFIN48FootnoteInd>
      <IndependentAuditFinclStmtInd referenceDocumentId="RetDoc3">false</IndependentAuditFinclStmtInd>
      <ConsolidatedAuditFinclStmtInd referenceDocumentId="RetDoc3">false</ConsolidatedAuditFinclStmtInd>
      <SchoolOperatingInd>false</SchoolOperatingInd>
      <ForeignOfficeInd>false</ForeignOfficeInd>
      <ForeignActivitiesInd>false</ForeignActivitiesInd>
      <MoreThan5000KToOrgInd>false</MoreThan5000KToOrgInd>
      <MoreThan5000KToIndividualsInd>false</MoreThan5000KToIndividualsInd>
      <ProfessionalFundraisingInd referenceDocumentId="RetDoc4">false</ProfessionalFundraisingInd>
      <FundraisingActivitiesInd referenceDocumentId="RetDoc4">true</FundraisingActivitiesInd>
      <GamingActivitiesInd referenceDocumentId="RetDoc4">false</GamingActivitiesInd>
      <OperateHospitalInd>false</OperateHospitalInd>
      <GrantsToOrganizationsInd referenceDocumentId="RetDoc5">true</GrantsToOrganizationsInd>
      <GrantsToIndividualsInd referenceDocumentId="RetDoc5">false</GrantsToIndividualsInd>
      <ScheduleJRequiredInd>false</ScheduleJRequiredInd>
      <TaxExemptBondsInd>false</TaxExemptBondsInd>
      <EngagedInExcessBenefitTransInd>false</EngagedInExcessBenefitTransInd>
      <PYExcessBenefitTransInd>false</PYExcessBenefitTransInd>
      <LoanOutstandingInd>false</LoanOutstandingInd>
      <GrantToRelatedPersonInd>false</GrantToRelatedPersonInd>
      <BusinessRlnWithOrgMemInd>false</BusinessRlnWithOrgMemInd>
      <BusinessRlnWithFamMemInd>false</BusinessRlnWithFamMemInd>
      <BusinessRlnWithOfficerEntInd>false</BusinessRlnWithOfficerEntInd>
      <DeductibleNonCashContriInd>false</DeductibleNonCashContriInd>
      <DeductibleArtContributionInd>false</DeductibleArtContributionInd>
      <TerminateOperationsInd>false</TerminateOperationsInd>
      <PartialLiquidationInd>false</PartialLiquidationInd>
      <DisregardedEntityInd>false</DisregardedEntityInd>
      <RelatedEntityInd>false</RelatedEntityInd>
      <RelatedOrganizationCtrlEntInd>false</RelatedOrganizationCtrlEntInd>
      <TrnsfrExmptNonChrtblRltdOrgInd>false</TrnsfrExmptNonChrtblRltdOrgInd>
      <ActivitiesConductedPrtshpInd>false</ActivitiesConductedPrtshpInd>
      <ScheduleORequiredInd>true</ScheduleORequiredInd>
      <IRPDocumentCnt>3</IRPDocumentCnt>
      <IRPDocumentW2GCnt>0</IRPDocumentW2GCnt>
      <BackupWthldComplianceInd>false</BackupWthldComplianceInd>
      <EmployeeCnt>1</EmployeeCnt>
      <EmploymentTaxReturnsFiledInd>true</EmploymentTaxReturnsFiledInd>
      <UnrelatedBusIncmOverLimitInd>false</UnrelatedBusIncmOverLimitInd>
      <ForeignFinancialAccountInd>false</ForeignFinancialAccountInd>
      <ProhibitedTaxShelterTransInd>false</ProhibitedTaxShelterTransInd>
      <TaxablePartyNotificationInd>false</TaxablePartyNotificationInd>
      <NondeductibleContributionsInd>false</NondeductibleContributionsInd>
      <IndoorTanningServicesInd>false</IndoorTanningServicesInd>
      <InfoInScheduleOPartVIInd>X</InfoInScheduleOPartVIInd>
      <GoverningBodyVotingMembersCnt>4</GoverningBodyVotingMembersCnt>
      <IndependentVotingMemberCnt>4</IndependentVotingMemberCnt>
      <FamilyOrBusinessRlnInd>false</FamilyOrBusinessRlnInd>
      <DelegationOfMgmtDutiesInd>false</DelegationOfMgmtDutiesInd>
      <ChangeToOrgDocumentsInd>false</ChangeToOrgDocumentsInd>
      <MaterialDiversionOrMisuseInd>false</MaterialDiversionOrMisuseInd>
      <MembersOrStockholdersInd>false</MembersOrStockholdersInd>
      <ElectionOfBoardMembersInd>false</ElectionOfBoardMembersInd>
      <DecisionsSubjectToApprovaInd>false</DecisionsSubjectToApprovaInd>
      <MinutesOfGoverningBodyInd>true</MinutesOfGoverningBodyInd>
      <MinutesOfCommitteesInd>true</MinutesOfCommitteesInd>
      <OfficerMailingAddressInd>false</OfficerMailingAddressInd>
      <LocalChaptersInd>false</LocalChaptersInd>
      <Form990ProvidedToGvrnBodyInd>true</Form990ProvidedToGvrnBodyInd>
      <ConflictOfInterestPolicyInd>true</ConflictOfInterestPolicyInd>
      <AnnualDisclosureCoveredPrsnInd>false</AnnualDisclosureCoveredPrsnInd>
      <RegularMonitoringEnfrcInd>true</RegularMonitoringEnfrcInd>
      <WhistleblowerPolicyInd>true</WhistleblowerPolicyInd>
      <DocumentRetentionPolicyInd>true</DocumentRetentionPolicyInd>
      <CompensationProcessCEOInd>false</CompensationProcessCEOInd>
      <CompensationProcessOtherInd>true</CompensationProcessOtherInd>
      <InvestmentInJointVentureInd>false</InvestmentInJointVentureInd>
      <StatesWhereCopyOfReturnIsFldCd>SC</StatesWhereCopyOfReturnIsFldCd>
      <OtherWebsiteInd>X</OtherWebsiteInd>
      <BooksInCareOfDetail>
        <PersonNm>WHITNEY RINGLER</PersonNm>
        <PhoneNum>8432702954</PhoneNum>
        <USAddress>
          <AddressLine1>123 PINE VALLEY DRIVE</AddressLine1>
          <City>SUMMERVILLE</City>
          <State>SC</State>
          <ZIPCode>29483</ZIPCode>
        </USAddress>
      </BooksInCareOfDetail>
      <NoListedPersonsCompensatedInd>X</NoListedPersonsCompensatedInd>
      <Form990PartVIISectionAGrp>
        <PersonNm>WHITNEY RINGLER</PersonNm>
        <TitleTxt>PRESIDENT</TitleTxt>
        <AverageHoursPerWeekRt>25.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DEBBIE RUPERT</PersonNm>
        <TitleTxt>BOARD OF DIR</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>LISA CATES</PersonNm>
        <TitleTxt>BOARD OF DIR</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>MICHELLE CARL</PersonNm>
        <TitleTxt>TREASURER</TitleTxt>
        <AverageHoursPerWeekRt>10.00</AverageHoursPerWeekRt>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <FormerOfcrEmployeesListedInd>false</FormerOfcrEmployeesListedInd>
      <TotalCompGreaterThan150KInd>false</TotalCompGreaterThan150KInd>
      <CompensationFromOtherSrcsInd>false</CompensationFromOtherSrcsInd>
      <AllOtherContributionsAmt>72291</AllOtherContributionsAmt>
      <TotalContributionsAmt>72291</TotalContributionsAmt>
      <FundraisingGrossIncomeAmt>158541</FundraisingGrossIncomeAmt>
      <FundraisingDirectExpensesAmt>53618</FundraisingDirectExpensesAmt>
      <NetIncmFromFundraisingEvtGrp>
        <TotalRevenueColumnAmt>104923</TotalRevenueColumnAmt>
      </NetIncmFromFundraisingEvtGrp>
      <GrossSalesOfInventoryAmt>8113</GrossSalesOfInventoryAmt>
      <CostOfGoodsSoldAmt>4786</CostOfGoodsSoldAmt>
      <NetIncomeOrLossGrp>
        <TotalRevenueColumnAmt>3327</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>3327</RelatedOrExemptFuncIncomeAmt>
      </NetIncomeOrLossGrp>
      <TotalRevenueGrp>
        <TotalRevenueColumnAmt>180541</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>3327</RelatedOrExemptFuncIncomeAmt>
      </TotalRevenueGrp>
      <GrantsToDomesticOrgsGrp>
        <TotalAmt>130000</TotalAmt>
        <ProgramServicesAmt>130000</ProgramServicesAmt>
      </GrantsToDomesticOrgsGrp>
      <OtherSalariesAndWagesGrp>
        <TotalAmt>25108</TotalAmt>
        <ProgramServicesAmt>7039</ProgramServicesAmt>
        <ManagementAndGeneralAmt>7139</ManagementAndGeneralAmt>
        <FundraisingAmt>10930</FundraisingAmt>
      </OtherSalariesAndWagesGrp>
      <PayrollTaxesGrp>
        <TotalAmt>1921</TotalAmt>
        <ProgramServicesAmt>576</ProgramServicesAmt>
        <ManagementAndGeneralAmt>576</ManagementAndGeneralAmt>
        <FundraisingAmt>769</FundraisingAmt>
      </PayrollTaxesGrp>
      <FeesForServicesOtherGrp>
        <TotalAmt>12488</TotalAmt>
        <ProgramServicesAmt>1244</ProgramServicesAmt>
        <FundraisingAmt>11244</FundraisingAmt>
      </FeesForServicesOtherGrp>
      <AdvertisingGrp>
        <TotalAmt>997</TotalAmt>
        <ProgramServicesAmt>864</ProgramServicesAmt>
        <FundraisingAmt>133</FundraisingAmt>
      </AdvertisingGrp>
      <OfficeExpensesGrp>
        <TotalAmt>1235</TotalAmt>
        <ManagementAndGeneralAmt>1235</ManagementAndGeneralAmt>
      </OfficeExpensesGrp>
      <TravelGrp>
        <TotalAmt>1506</TotalAmt>
        <ManagementAndGeneralAmt>1506</ManagementAndGeneralAmt>
      </TravelGrp>
      <ConferencesMeetingsGrp>
        <TotalAmt>514</TotalAmt>
        <ManagementAndGeneralAmt>514</ManagementAndGeneralAmt>
      </ConferencesMeetingsGrp>
      <InsuranceGrp>
        <TotalAmt>1400</TotalAmt>
        <ManagementAndGeneralAmt>1400</ManagementAndGeneralAmt>
      </InsuranceGrp>
      <OtherExpensesGrp>
        <Desc>PROMOTIONAL GIVE-AWAY</Desc>
        <TotalAmt>1402</TotalAmt>
        <ProgramServicesAmt>1402</ProgramServicesAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>CONTINUING EDUCATION</Desc>
        <TotalAmt>770</TotalAmt>
        <ManagementAndGeneralAmt>770</ManagementAndGeneralAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>CONSTANT CONTACT</Desc>
        <TotalAmt>725</TotalAmt>
        <ProgramServicesAmt>725</ProgramServicesAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>TELEPHONE</Desc>
        <TotalAmt>720</TotalAmt>
        <ManagementAndGeneralAmt>720</ManagementAndGeneralAmt>
      </OtherExpensesGrp>
      <AllOtherExpensesGrp>
        <TotalAmt>3033</TotalAmt>
        <ProgramServicesAmt>667</ProgramServicesAmt>
        <ManagementAndGeneralAmt>2108</ManagementAndGeneralAmt>
        <FundraisingAmt>258</FundraisingAmt>
      </AllOtherExpensesGrp>
      <TotalFunctionalExpensesGrp>
        <TotalAmt>181819</TotalAmt>
        <ProgramServicesAmt>142517</ProgramServicesAmt>
        <ManagementAndGeneralAmt>15968</ManagementAndGeneralAmt>
        <FundraisingAmt>23334</FundraisingAmt>
      </TotalFunctionalExpensesGrp>
      <CashNonInterestBearingGrp>
        <BOYAmt>43763</BOYAmt>
        <EOYAmt>38562</EOYAmt>
      </CashNonInterestBearingGrp>
      <InventoriesForSaleOrUseGrp>
        <BOYAmt>1363</BOYAmt>
        <EOYAmt>3931</EOYAmt>
      </InventoriesForSaleOrUseGrp>
      <PrepaidExpensesDefrdChargesGrp>
        <EOYAmt>1544</EOYAmt>
      </PrepaidExpensesDefrdChargesGrp>
      <TotalAssetsGrp>
        <BOYAmt>45126</BOYAmt>
        <EOYAmt>44037</EOYAmt>
      </TotalAssetsGrp>
      <AccountsPayableAccrExpnssGrp>
        <BOYAmt>1791</BOYAmt>
        <EOYAmt>1980</EOYAmt>
      </AccountsPayableAccrExpnssGrp>
      <TotalLiabilitiesGrp>
        <BOYAmt>1791</BOYAmt>
        <EOYAmt>1980</EOYAmt>
      </TotalLiabilitiesGrp>
      <OrgDoesNotFollowSFAS117Ind>X</OrgDoesNotFollowSFAS117Ind>
      <PdInCapSrplsLandBldgEqpFundGrp>
        <BOYAmt>5500</BOYAmt>
        <EOYAmt>5500</EOYAmt>
      </PdInCapSrplsLandBldgEqpFundGrp>
      <RtnEarnEndowmentIncmOthFndsGrp>
        <BOYAmt>37835</BOYAmt>
        <EOYAmt>36557</EOYAmt>
      </RtnEarnEndowmentIncmOthFndsGrp>
      <TotalNetAssetsFundBalanceGrp>
        <BOYAmt>43335</BOYAmt>
        <EOYAmt>42057</EOYAmt>
      </TotalNetAssetsFundBalanceGrp>
      <TotLiabNetAssetsFundBalanceGrp>
        <BOYAmt>45126</BOYAmt>
        <EOYAmt>44037</EOYAmt>
      </TotLiabNetAssetsFundBalanceGrp>
      <ReconcilationRevenueExpnssAmt>-1278</ReconcilationRevenueExpnssAmt>
      <MethodOfAccountingAccrualInd>X</MethodOfAccountingAccrualInd>
      <AccountantCompileOrReviewInd>false</AccountantCompileOrReviewInd>
      <FSAuditedInd>false</FSAuditedInd>
      <FederalGrantAuditRequiredInd>false</FederalGrantAuditRequiredInd>
    </IRS990>
    <IRS990ScheduleA documentId="RetDoc2">
      <PublicOrganization170Ind>X</PublicOrganization170Ind>
      <GiftsGrantsContriRcvd170Grp>
        <CurrentTaxYearMinus3YearsAmt>33539</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>6936</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>18052</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>72291</CurrentTaxYearAmt>
        <TotalAmt>130818</TotalAmt>
      </GiftsGrantsContriRcvd170Grp>
      <TotalCalendarYear170Grp>
        <CurrentTaxYearMinus3YearsAmt>33539</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>6936</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>18052</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>72291</CurrentTaxYearAmt>
        <TotalAmt>130818</TotalAmt>
      </TotalCalendarYear170Grp>
      <PublicSupportTotal170Amt>130818</PublicSupportTotal170Amt>
      <TotalSupportAmt>130818</TotalSupportAmt>
      <GrossReceiptsRltdActivitiesAmt>166654</GrossReceiptsRltdActivitiesAmt>
      <PublicSupportCY170Pct>1.00000</PublicSupportCY170Pct>
      <PublicSupportPY170Pct>1.00000</PublicSupportPY170Pct>
      <ThirtyThrPctSuprtTestsCY170Ind>X</ThirtyThrPctSuprtTestsCY170Ind>
    </IRS990ScheduleA>
    <IRS990ScheduleD documentId="RetDoc3">
      <DisclosedOrgLegCtrlInd>false</DisclosedOrgLegCtrlInd>
      <DisclosedForCharitablePrpsInd>false</DisclosedForCharitablePrpsInd>
    </IRS990ScheduleD>
    <IRS990ScheduleG documentId="RetDoc4">
      <LicensedStatesCd>SC</LicensedStatesCd>
      <FundraisingEventInformationGrp>
        <NameOfEvent1Amt>GALA AUCTION</NameOfEvent1Amt>
        <GrossReceiptsEvent1Amt>97744</GrossReceiptsEvent1Amt>
        <GrossRevenueEvent1Amt>97744</GrossRevenueEvent1Amt>
        <OtherDirectExpensesEvent1Amt>37110</OtherDirectExpensesEvent1Amt>
        <NameOfEvent2Amt>SCHOOLS</NameOfEvent2Amt>
        <GrossReceiptsEvent2Amt>15466</GrossReceiptsEvent2Amt>
        <GrossRevenueEvent2Amt>15466</GrossRevenueEvent2Amt>
        <OtherDirectExpensesEvent2Amt>545</OtherDirectExpensesEvent2Amt>
        <OtherEventsTotalCnt>2</OtherEventsTotalCnt>
        <GrossReceiptsOtherEventsAmt>25000</GrossReceiptsOtherEventsAmt>
        <GrossRevenueOtherEventsAmt>25000</GrossRevenueOtherEventsAmt>
        <OthDirectExpnssOtherEventsAmt>5561</OthDirectExpnssOtherEventsAmt>
        <GrossReceiptsTotalAmt>138210</GrossReceiptsTotalAmt>
        <GrossRevenueTotalEventsAmt>138210</GrossRevenueTotalEventsAmt>
        <OthDirectExpnssTotalEventsAmt>43216</OthDirectExpnssTotalEventsAmt>
        <DirectExpenseSummaryEventsAmt>43216</DirectExpenseSummaryEventsAmt>
        <NetIncomeSummaryAmt>94994</NetIncomeSummaryAmt>
      </FundraisingEventInformationGrp>
    </IRS990ScheduleG>
    <IRS990ScheduleI documentId="RetDoc5">
      <GrantRecordsMaintainedInd>false</GrantRecordsMaintainedInd>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1>MEDICAL UNIVERSITY OF SC</BusinessNameLine1>
          <BusinessNameLine2>MEDICAL UNIVERSITY OF SC</BusinessNameLine2>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1>171 ASHLEY AVE</AddressLine1>
          <City>CHARLESTON</City>
          <State>SC</State>
          <ZIPCode>29425</ZIPCode>
        </USAddress>
        <RecipientEIN>576028985</RecipientEIN>
        <CashGrantAmt>130000</CashGrantAmt>
        <PurposeOfGrantTxt>CANCER RESEARCH</PurposeOfGrantTxt>
      </RecipientTable>
    </IRS990ScheduleI>
    <IRS990ScheduleO documentId="RetDoc6">
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990 - ORGANIZATION'S MISSION</FormAndLineReferenceDesc>
        <ExplanationTxt>CHASE AFTER A CURE IS A NON-PROFIT CORPORATION DEDICATED TO CHILDREN'S CANCER RESEARCH. WE RAISE AWARENESS FOR CHILDREN'S CANCER AND PROVIDE FUNDING FOR RESEARCH LABS WHO SPECIALIZE IN CHILDREN'S CANCER RESEARCH. OUR MAIN FOCUS FOR RESEARCH IS THE MORE AGGRESSIVE AND DEADLY CANCER CALLED NEUROBLASOMA.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 2, PART III, LINE 4A</FormAndLineReferenceDesc>
        <ExplanationTxt>APPLIED AND WERE AWARDED A 10,000 GRANT FROM THE EXCHANGE CLUB OF CHARLESTON. FUNDS FROM THIS GRANT WERE REQUESTED TO HELP FUND THE PURCHASE OF AN IMAGER IN THE LAB TO STUDY THE AMOUNTS OF SPHINGOLIPID PROTEIN IN NEUROBLASTOMA CELL LINES AND TUMORS. THIS DEVICE WILL ALSO MEASURE THE CHANGES IN THE AMOUNTS OF PROTEIN IN NEUROBLASTOMA CELLS AND TUMORS AFTER TREATMENTS WITH THE INHIBITORS DEVELOPED BY THE LAB. SUPPORT FOR CHASE AFTER A CURE HAS RESULTED IN 10 PUBLICATIONS, OVER 200 CITATIONS, 3 INVITED PRESENTATIONS, 15 ORAL AND POSTER PRESENTATIONS, AND NATIONAL AND INTERNATIONAL MEETINGS. THE LOCAL RESEARCH LAB WAS ABLE TO GENERATE PRELIMINARY DATA THAT SUPPORTED PROPOSALS FOR PEER-REVIEWED FUNDING FROM THE NATIONAL CHILDHOOD CANCER FOUNDATIONS, HYUNDAI HOPE ON WHEELS, RALLY FOUNDATION FOR PEDIATRIC CANCER RESEARCH, AND THE ST. BALDRICK'S FOUNDATION. FUNDS HAVE HELPED SUPPORT THE WORK OF THREE SCIENTISTS IN THE LAB. PURCHASE KEY EQUIPMENT FOR THE LAB SUCH AS: EVOS FLOURESCENT MIRCROSCOPE USED TO VISUALIZE DRUG TREATMENTS, BIOTEK SYNERGY H1 MULTI-MODE PLATE READER USED FOR CANCER CELL DEATH ASSAYS, ENZYME ASSAYS, CANCER CELL DRUG DISCOVERY EXPERIMENTS, AND BIORAD CFX96 TOUCH REAL-TIME PCR THERMAL CYCLER USED FOR CANCER CELL GENE EXPRESSION ANALYSIS. SUBSIDIZED THE COST OF LAB EXPERIMENTS AND CONSUMABLES SUCH AS REAGENTS, PIPETTES, AND TISSUE CULTURE PLATES.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 6, PART VI, LINE 11B</FormAndLineReferenceDesc>
        <ExplanationTxt>THE BOARD WILL REVIEW THE 990.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 6, PART VI, LINE 12C</FormAndLineReferenceDesc>
        <ExplanationTxt>BOARD MEMBERS HAVE BEEN MADE AWARE OF THE POLICY AND HAVE BEEN DIRECTED AS TO THE LOCATION OF SUCH POLICIES.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 6, PART VI, LINE 15B</FormAndLineReferenceDesc>
        <ExplanationTxt>THE BOARD OF DIRECTORS ASSESSES THE EXECUTIVE DIRECTOR'S PERFORMANCE AT THE END OF EACH FISCAL YEAR. IN ADDITION, THE BOARD RESEARCHED VARIOUS OTHER NONPROFITS THAT WERE LARGER AND OF SIMILAR SIZE TO NOTATE HOW MUCH OTHER EXECUTIVE DIRECTORS ARE PAID. BASED ON THE FISCAL YEAR-END EVALUATION, A DECISION WAS MADE BY THE BOARD FOR THE COMPENSATION OF THE EXECUTIVE DIRECTOR. THE COMPENSATION DECISION IS DOCUMENTED IN THE MINUTES OF THE BOARD MEETING.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 6, PART VI, LINE 19</FormAndLineReferenceDesc>
        <ExplanationTxt>GUIDESTAR</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleO>
  </ReturnData>
</Return>